Investigational Site Number : 8260016

London, London, City of Se1 7eh

2 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Dermatitis Atopic

Studies at this site

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype — Recruiting now
• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials — Enrolling by invitation